Financial Architects (New Jersey)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-500
| Closed | -$29K | – | 615 |
|
|
2020
Q2 | $29K | Hold |
500
| – | – | 0.01% | 492 |
|
|
2020
Q1 | $23K | Hold |
500
| – | – | 0.01% | 485 |
|
|
2019
Q4 | $28K | Hold |
500
| – | – | 0.01% | 517 |
|
|
2019
Q3 | $24K | Hold |
500
| – | – | 0.01% | 552 |
|
|
2019
Q2 | $27K | Hold |
500
| – | – | 0.01% | 560 |
|
|
2019
Q1 | $28K | Hold |
500
| – | – | ﹤0.01% | 694 |
|
|
2018
Q4 | $24K | Hold |
500
| – | – | ﹤0.01% | 683 |
|
|
2018
Q3 | $30K | Hold |
500
| – | – | ﹤0.01% | 694 |
|
|
2018
Q2 | $27K | Hold |
500
| – | – | ﹤0.01% | 732 |
|
|
2018
Q1 | $25K | Hold |
500
| – | – | ﹤0.01% | 719 |
|
|
2017
Q4 | $24K | Hold |
500
| – | – | ﹤0.01% | 810 |
|
|
2017
Q3 | $25K | Hold |
500
| – | – | ﹤0.01% | 815 |
|
|
2017
Q2 | $23K | Hold |
500
| – | – | ﹤0.01% | 814 |
|
|
2017
Q1 | $21K | Sell |
500
-250
| -33% | -$10.5K | ﹤0.01% | 834 |
|
|
2016
Q4 | $29K | Hold |
750
| – | – | 0.01% | 727 |
|
|
2016
Q3 | $31K | Hold |
750
| – | – | 0.01% | 711 |
|
|
2016
Q2 | $28K | Hold |
750
| – | – | 0.01% | 691 |
|
|
2016
Q1 | $29K | Buy |
+750
| New | +$29K | 0.01% | 499 |
|
|
2015
Q3 | – | Sell |
-750
| Closed | -$44K | – | 683 |
|
|
2015
Q2 | $44K | Buy |
+750
| New | +$44K | 0.02% | 454 |
|
|
2015
Q1 | – | Sell |
-750
| Closed | -$38K | – | 985 |
|
|
2014
Q4 | $38K | Hold |
750
| – | – | 0.02% | 390 |
|
|
2014
Q3 | $35K | Hold |
750
| – | – | 0.02% | 365 |
|
|
2014
Q2 | $33K | Buy |
+750
| New | +$33K | 0.02% | 389 |
|
|
2013
Q4 | – | Sell |
-750
| Closed | -$26K | – | 436 |
|
|
2013
Q3 | $26K | Hold |
750
| – | – | 0.02% | 336 |
|
|
2013
Q2 | $22K | Buy |
+750
| New | +$22K | 0.02% | 346 |
|